Acurx Stock Today

ACXP
 Stock
  

USD 3.13  0.17  5.15%   

Market Performance
0 of 100
Odds Of Distress
Less than 42
Acurx Pharmaceuticals is selling at 3.13 as of the 4th of December 2022; that is -5.15 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 3.12. Acurx Pharmaceuticals has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Acurx Pharmaceuticals LLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2022 and ending today, the 4th of December 2022. Click here to learn more.
Fiscal Year End
December
IPO Date
25th of June 2021
Category
Healthcare
ISIN
US00510M1045
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York. Acurx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 11.59 M outstanding shares of which 23.14 K shares are presently shorted by private and institutional investors with about 1.01 trading days to cover. More on Acurx Pharmaceuticals LLC
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Acurx Pharmaceuticals Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Acurx Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Acurx Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Acurx Pharmaceuticals has very high historical volatility over the last 90 days
Net Loss for the year was (12.75 M) with profit before overhead, payroll, taxes, and interest of 0.
Acurx Pharmaceuticals LLC currently holds about 9.09 M in cash with (5.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Roughly 21.0% of the company shares are held by company insiders
Average Analyst Recommendation
Analysts covering Acurx Pharmaceuticals report their recommendations after researching Acurx Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Acurx Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Acurx Pharmaceuticals LLC. The Acurx consensus assessment is calculated by taking the average forecast from all of the analysts covering Acurx Pharmaceuticals.
Strong Buy1 Opinion
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Acurx Pharmaceuticals' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Acurx Pharmaceuticals LLC (ACXP) is traded on NASDAQ Exchange in USA and employs 4 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 38.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acurx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Acurx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Acurx Pharmaceuticals LLC conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 11.59 M outstanding shares of which 23.14 K shares are presently shorted by private and institutional investors with about 1.01 trading days to cover. Acurx Pharmaceuticals LLC currently holds about 9.09 M in cash with (5.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Check Acurx Pharmaceuticals Probability Of Bankruptcy
Ownership
Acurx Pharmaceuticals LLC retains a total of 11.59 Million outstanding shares. Acurx Pharmaceuticals LLC retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Acurx Ownership Details

Acurx Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Acurx Pharmaceuticals jumping above the current price in 90 days from now is about 63.06%. The Acurx Pharmaceuticals LLC probability density function shows the probability of Acurx Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Acurx Pharmaceuticals has a beta of 0.6314. This suggests as returns on the market go up, Acurx Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Acurx Pharmaceuticals LLC will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Acurx Pharmaceuticals LLC is significantly underperforming NYSE Composite.
  Odds Below 3.13HorizonTargetOdds Above 3.13
36.82%90 days
 3.13 
63.06%
Based on a normal probability distribution, the odds of Acurx Pharmaceuticals to move above the current price in 90 days from now is about 63.06 (This Acurx Pharmaceuticals LLC probability density function shows the probability of Acurx Stock to fall within a particular range of prices over 90 days) .

Acurx Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Acurx Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Acurx Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Acurx Pharmaceuticals' value.
InstituionSecurity TypeTotal SharesValue
Wells Fargo CompanyCommon Shares58.00.0
Wells Fargo CompanyCommon Shares18.00.0
View Acurx Pharmaceuticals Diagnostics

Acurx Pharmaceuticals LLC Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Acurx Pharmaceuticals market risk premium is the additional return an investor will receive from holding Acurx Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Acurx Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Acurx Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Acurx Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Acurx Stock Against Markets

Picking the right benchmark for Acurx Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Acurx Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Acurx Pharmaceuticals is critical whether you are bullish or bearish towards Acurx Pharmaceuticals LLC at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Acurx Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Invested in Acurx Pharmaceuticals LLC?

The danger of trading Acurx Pharmaceuticals LLC is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Acurx Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Acurx Pharmaceuticals. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Acurx Pharmaceuticals LLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for analysis

When running Acurx Pharmaceuticals LLC price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is Acurx Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acurx Pharmaceuticals. If investors know Acurx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acurx Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
38.3 M
Return On Assets
(0.55) 
Return On Equity
(0.95) 
The market value of Acurx Pharmaceuticals LLC is measured differently than its book value, which is the value of Acurx that is recorded on the company's balance sheet. Investors also form their own opinion of Acurx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acurx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acurx Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acurx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acurx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Acurx Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acurx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.